In the News
Latest News:
What’s Next for Eli Lilly Alzheimer’s Drug Donanemab? Trial Enrollment Continues.
March 15, 2021
Being Patient
A 73-Year-Old-Woman Who Should Have Gotten Alzheimer's, Didn't—Revitalizing a Search for the Cure
December 07, 2020
Newsweek
Alzheimer’s Prevention Registry’s GeneMatch Program seeking interested Marketing/Creative Firms for its Request For Proposals (RFP) bid
November 23, 2020